Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations

19 Nov 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Bacteriophages and microbial interactions
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22115954
DOI: 10.1016/j.jbiotec.2011.11.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulationsPMID 22115954Read ↗

Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever.Semantic proximity Read ↗

Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity.Semantic proximity Read ↗

Outer Membrane Vesicle Vaccine PlatformsSemantic proximity Read ↗

Comparative immunogenicity of M. hyopneumoniae NrdF encoded in different expression systems delivered orally via attenuated S. typhimurium aroA in miceSemantic proximity Read ↗

Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.Semantic proximity Read ↗

An Engineered SARS-CoV-2 S1 Glycoprotein Produced in Pichia pastoris as a Candidate Vaccine AntigenSemantic proximity Read ↗

Lipopolysaccharide: a tool and target in enterobacterial vaccine development.Semantic proximity Read ↗

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.Semantic proximity Read ↗

Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systemsSemantic proximity Read ↗

Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 systemSemantic proximity Read ↗

Recombinant immune complexes as vaccines against infectious diseasesSemantic proximity Read ↗

Outer membrane vesicles as platform vaccine technologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.